Delivery Order SPE2DB20D2104-SPE2DB24FS23S
Award Date
1/25/24
Potential Completion Date
1/26/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D6036|SPE2DB23FC8JN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,096.15 firm-fixed-price delivery order is for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, a critical medical product. The contract has an ultimate completion date of May 4, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,905.04 delivery order contract is for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, a critical respiratory medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp's parent company, Cencora, Inc., with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,556,138,924 units of Albuterol HFA 90 MCG Inhaler 8.5GM. The $8,560.86 firm fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (doing business as Amerisourcebergen) holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,120.20, is for the delivery of Albuterol HFA 90 MCG inhalers over the period ending on October 8, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,041.47 firm fixed-price delivery order is for the procurement of 4,566,437,175 units of Albuterol HFA 90 MCG Inhaler, 8.5GM, with a completion date of November 15, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) under a Delivery Order valued at $1,171.89. The contract is for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, a critical medical commodity used in respiratory care. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,836.06 Firm Fixed Price Delivery Order is for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, a critical medication used to treat respiratory conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc.,...
This federal contract award, with an ID of SPE2DB22D3501|SPE2DB24FUA55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,751.84 Firm Fixed Price Delivery Order contract is for the supply of 4563216655 ! ALBUTEROL HFA 90 MCG INHALER 8.5GM, a critical medical commodity. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is for the delivery of Albuterol HFA 90 MCG Inhaler 8.5GM to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of Cencora, Inc. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,561,489,105 units of the Albuterol HFA 90 MCG Inhaler 8.5GM. The award, valued at $1,656.96, is a firm fixed-price delivery order contract with a completion date of July 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...